4//SEC Filing
VAN BEEK JEROEN B 4
Accession 0000899243-22-013331
CIK 0001754068other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:22 PM ET
Size
7.5 KB
Accession
0000899243-22-013331
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
VAN BEEK JEROEN B
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-01-18+23,256→ 405,640 total - Award
Stock Option (Right to Buy)
2022-01-18+56,744→ 56,744 totalExercise: $9.15Exp: 2032-01-18→ Common Stock (56,744 underlying)
Footnotes (2)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on January 18, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.
- [F2]25% of this option shall vest and become exercisable on January 18, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.
Documents
Issuer
Allovir, Inc.
CIK 0001754068
Entity typeother
Related Parties
1- filerCIK 0001743662
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:22 PM ET
- Size
- 7.5 KB